DRIO DarioHealth Corp. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

Period return

-4.73 (-40.32%)

Volume

10.5K

2026-07-21O $7 H $7 L $6.68 C $7MA5 $6.82MA20 $6.78MA60 $7.34MA120 $8.26

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 08. 14.Highin 24 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 15.LowBUY2 months ago
Stifel: Buy
US analyst rating / recommendation change.
2026. 05. 14.LowHOLD2 months ago
TD Cowen: Hold
US analyst rating / recommendation change.
2026. 03. 21.LowBUY4 months ago
Stifel: Buy
US analyst rating / recommendation change.
2025. 05. 20.MediumBUYlast year
Litchfield Hills: Buy
US analyst rating / recommendation change.
2025. 03. 11.LowBUYlast year
Stifel: Buy
US analyst rating / recommendation change.
2024. 04. 02.LowBUY2 years ago
Stifel: Buy
US analyst rating / recommendation change.
2023. 08. 11.LowBUY3 years ago
Alliance Global Partners: Buy
US analyst rating / recommendation change.
2023. 07. 25.LowBUY3 years ago
Stifel: Buy
US analyst rating / recommendation change.
2023. 05. 12.LowBUY3 years ago
Craig-Hallum: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $18.5 · 4 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Sector: Healthcare
Industry: Health Information Services
HQ: New York, NY, United States
Fiscal year end: —
Employees: 160

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 14.	After market close (AMC)	$-0.76	—	—	$5.92M	—	Scheduled
FY2019 Q2	2018. 06. 30.	Time TBD	—	—	—	—	$3.82M	Reported
FY2019 Q1	2018. 03. 31.	Time TBD	—	—	—	—	$1.76M	Reported
FY2018 Q3	2017. 09. 30.	Time TBD	—	—	—	—	$3.59M	Reported

DarioHealth Corp.

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 15.	Stifel	—	Maintain	Buy → Buy	—	Stifel: Buy
2026. 05. 14.	TD Cowen	—	Maintain	Hold → Hold	—	TD Cowen: Hold
2026. 03. 21.	Stifel	—	Maintain	Buy → Buy	—	Stifel: Buy
2025. 05. 20.	Litchfield Hills	—	Initiate coverage	— → Buy	—	Litchfield Hills: Buy
2025. 03. 11.	Stifel	—	Maintain	Buy → Buy	—	Stifel: Buy
2024. 04. 02.	Stifel	—	Maintain	Buy → Buy	—	Stifel: Buy